About US
Contact us
-
NovaBiotics Initiates Development of Orphan Drug in Cystic FibrosisNovaBiotics Ltd, the Aberdeen-based clinical-stage biotechnology company has initiated the development of an inhaled form of Lynovex, its treatment for cystic fibrosis (CF). Lynovex is an orphan dr2013/12/18
-
Recipharm Subsidiary Files Infectious Disease Drug Applicatio​n in European MarketRPH Pharmaceuticals AB, a subsidiary ofRecipharm AB,has filed anapplication for an infectious disease drug product in a range of European countries. The product has been developed through a partnershi2013/12/17
-
Recipharm Subsidiary Files Infectious Disease Drug Applicatio​n in European MarketRPH Pharmaceuticals AB, a subsidiary ofRecipharm AB,has filed anapplication for an infectious disease drug product in a range of European countries. The product has been developed through a partnershi2013/12/17
-
China rounds up counterfeiters as the FDA boosts its oversight thereChinaagreed this month to allow the U.S. FDA to send more people there so it can boost its oversight of Chinese drug production. But as if to prove that it has the situation under control, Chinese aut2013/12/17
-
NIH Network Revolutionises Stroke Clinical ResearchA network of 25 regional stroke centers working with nearby satellite facilities will span the country, have teams of researchers representing every medical specialty needed for stroke care and will a2013/12/16
-
FDA Approves First Generic Versions of Antidepressant Drug CymbaltaFDA hasapproved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and other conditions. Aurobindo Pharma Ltd, Dr Reddy’s2013/12/16
-
Roche and Prothena to jointly develop and promote antibodies for Parkinson's treatmentRoche and Prothena have entered into a collaboration to develop and commercialise antibodies that target alpha-synuclein, including PRX002, Prothena's monoclonal antibody for the treatment of Parkinso2013/12/13
-
FDA Advisory Committee Votes on Investigational Medicine MetreleptinAstraZeneca and Bristol-Myers Squibb Companyhave announced that FDA Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) recommends the investigational medicine metreleptin for the treatment2013/12/13
-
CVS Caremark and Cardinal Health Announce Creation of Largest Generic Sourcing Entity in USCVS Caremark and Cardinal Healthhave signedan agreement to form the largest generic sourcing entity in the US, which is the world's largest generic drug market. Both companies are contributing their s2013/12/12
-
£3 Million Dementia Consortium Launched to Boost Dementia Drug DiscoveryAs the UK today hosts the first G8 summit on dementia research, a new £3 million Dementia Consortium bringing together research experts from the charitable, academic and private sectors has laun2013/12/12